Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: J Clin Hypertens (Greenwich). 2019 May 24;21(6):838–850. doi: 10.1111/jch.13561

Table 4.

Factors Associated with Hypertension among Ghanaians living with HIV on cART and those cART naïve

Predictor PLWH on cART PLWH not on cART
Unadjusted OR (95% CI) Adjusted OR (95% CI) Unadjusted OR (95% CI) Adjusted OR (95% CI)
Age, each 10-years older 1.99(1.44–2.74) 2.17(1.553.03) 1.92 (1.31–2.82) 1.92 (1.262.92)
Male sex 1.35 (0.71–2.57) -- 1.27 (0.56–2.87) --
CD4 T-cell count, each 100 cells/mm3 higher 1.05 (0.93–1.19) -- 1.15 (1.01–1.27) 1.09 (0.96–1.23)
WHO Clinical stages, each stage higher 1.03 (0.80–1.34) -- 1.78 (0.90–3.53) --
Duration of cART exposure in years 1.00 (0.93 – 1.08) -- N/A N/A
Viral load <40copies/ml 1.47 (0.84 – 2.59) -- 0.83 (0.59–1.16)** --
Efavirenz based cART versus Nevirapine based cART (referent) 1.42 (0.83–2.43) -- N/A N/A
Family History of hypertension 1.24 (0.90–1.70) -- 1.89 (1.28–2.78) 1.72 (1.122.65)
Body mass index, each 5kg/m2 rise 1.31 (1.03–1.66) 1.46(1.131.87) 1.67 (1.20–2.32) 1.47 (1.002.16)
Total serum cholesterol>5.2mmol/l 0.61 (0.36–1.04) -- 0.63 (0.32 – 1.21) --
Total serum triglyceride >1.70mmol/l 0.56 (0.30–1.06) -- 0.36 (0.15 – 0.87) 0.46 (0.18– 1.16)
Estimated glomerular filtration rate, each 15ml/min higher 1.10 (0.75–1.62) -- 1.18 (0.94–1.48) --
Cigarette use 0.72 (0.24–2.11) -- 1.20 (0.31–4.73) --
Physical activity 1.04 (0.61–1.77) -- 1.11 (0.50–2.45) --
Table added salt 1.24 (0.71–2.16) -- 0.99 (0.72–1.35) --
Vegetable servings 1.02 (0.75–1.39) -- 0.95 (0.72–1.35) --
Fruit servings 0.93 (0.80–1.08) -- 1.10 (0.90–1.35) --
Alcohol use 0.56 (0.20–1.60) -- 1.84 (0.64–5.27) --
**

Viral load, each log higher